Scandinavian ChemoTech announced a 6MSEK growth loan from a major Swedish financial institution. This non-dilutive funding is a central piece of the company’s financial strategy, primarily intended to accelerate the expansion of its Animal Care segment. We view this announcement as a sign of strength, particularly highlighting the favourable interest rate compared to the company’s current debt facilities.
LÄS MER
